Article Text

Download PDFPDF
Endogenous heparinoids in acute variceal bleeding
  1. U Thalheimer1,
  2. C Triantos1,
  3. D Samonakis1,
  4. D Patch1,
  5. A K Burroughs1,
  6. A Riddell2,
  7. D Perry2
  1. 1Liver Transplant and Hepatobiliary Medicine Unit, Royal Free Hospital, London, UK
  2. 2Haemophilia Unit, Royal Free Hospital, London, UK
  1. Correspondence to:
    Professor A K Burroughs
    Liver Transplant and Hepatobiliary Medicine Unit, Royal Free Hospital, Pond St, London NW3 2QG, UK; Andrew.Burroughsroyalfree.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The risk of variceal bleeding in cirrhotics is associated with increasing liver dysfunction, larger varices, endoscopic red signs, and higher portal pressure. However, why bleeding occurs unpredictably and infrequently in individual patients is unknown.

Bacterial infections occur in 35–66% of cirrhotics presenting with gastrointestinal bleeding.1 We proposed a possible pathophysiological basis linking infection and variceal bleeding via endotoxin induced endothelin release and subsequent portal pressure rise, combined with impaired platelet aggregation due to endotoxin induced nitric oxide and prostacyclin.2 Infected cirrhotics demonstrate a heparin effect using heparinase I modified thromboelastography (TEG) and have anti-Xa activity.3,4 Now we show similar findings in two cirrhotics during the course of acute variceal bleeding.

Patient 1 was male, 66 years old (Child-Pugh grade C), and patient 2 was female, 42 years old …

View Full Text

Footnotes

  • Conflict of interest: None declared.